These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy. St'astný M; Plocová D; Etrych T; Kovár M; Ulbrich K; Ríhová B J Control Release; 2002 May; 81(1-2):101-11. PubMed ID: 11992683 [TBL] [Abstract][Full Text] [Related]
6. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Tijerina M; Fowers KD; Kopecková P; Kopecek J Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494 [TBL] [Abstract][Full Text] [Related]
7. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257 [TBL] [Abstract][Full Text] [Related]
8. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307 [TBL] [Abstract][Full Text] [Related]
9. HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia. St'astný M; Plocová D; Etrych T; Ulbrich K; Ríhová B Eur J Cancer; 2002 Mar; 38(4):602-8. PubMed ID: 11872356 [TBL] [Abstract][Full Text] [Related]
10. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135 [TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. Minko T; Kopecková P; Pozharov V; Kopecek J J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909 [TBL] [Abstract][Full Text] [Related]
12. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate. Leontieva OV; Preobrazhenskaya MN; Bernacki RJ Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193 [TBL] [Abstract][Full Text] [Related]
13. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators. Ríhová B; Jelínková M; Strohalm J; Subr V; Plocová D; Hovorka O; Novák M; Plundrová D; Germano Y; Ulbrich K J Control Release; 2000 Feb; 64(1-3):241-61. PubMed ID: 10640661 [TBL] [Abstract][Full Text] [Related]
14. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Omelyanenko V; Gentry C; Kopecková P; Kopecek J Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13. Kovár M; Strohalm J; Ulbrich K; Ríhová B J Drug Target; 2002 Feb; 10(1):23-30. PubMed ID: 11996083 [TBL] [Abstract][Full Text] [Related]
16. Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers. Machová D; Koziolová E; Chytil P; Venclíková K; Etrych T; Janoušková O Eur J Pharm Biopharm; 2018 Oct; 131():141-150. PubMed ID: 30075311 [TBL] [Abstract][Full Text] [Related]
17. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Kunath K; Kopecková P; Minko T; Kopecek J Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922 [TBL] [Abstract][Full Text] [Related]
18. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. David A; Kopecková P; Minko T; Rubinstein A; Kopecek J Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799 [TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene. Ríhová B; Jelínková M; Strohalm J; St'astný M; Hovorka O; Plocová D; Kovár M; Dráberová L; Ulbrich K Bioconjug Chem; 2000; 11(5):664-73. PubMed ID: 10995209 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance. Liu Y; Zhou Z; Lin X; Xiong X; Zhou R; Zhou M; Huang Y Biomacromolecules; 2019 Oct; 20(10):3755-3766. PubMed ID: 31465208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]